Slingshot members are tracking this event:

Actinium (ATNM) Initiates Phase 2 Trial Evaluating Actimab-A in Newly Diagnosed Acute Myeloid Leukemia Patients Over Age 60

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 27, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Trial Initiation, Phase 2, Actimab-a, Newly Diagnosed Acute Myeloid Leukemia, Age 60